Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Clinical Cancer Research|2014Cited by 143
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOPAlexandar Tzankov, Ken H. Young, Zijun Y. Xu‐Monette et al.|Modern Pathology|2013Cited by 129
Clinical and biological significance of<i>de novo</i>CD5+ diffuse large B-cell lymphoma in Western countriesZijun Y. Xu‐Monette, Ken H. Young, Meifeng Tu et al.|Oncotarget|2015Cited by 93
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaJiayu Chen, Ken H. Young, John P. Farnen et al.|Oncotarget|2015Cited by 80
Clinical Implications of Phosphorylated STAT3 Expression in <i>De Novo</i> Diffuse Large B-cell LymphomaChi Young Ok, Ken H. Young, Jiayu Chen et al.|Clinical Cancer Research|2014Cited by 68